<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04758195</url>
  </required_header>
  <id_info>
    <org_study_id>E2021004</org_study_id>
    <nct_id>NCT04758195</nct_id>
  </id_info>
  <brief_title>Transanal Irrigation to Prevent Major Low Anterior Resection Syndrome</brief_title>
  <acronym>TAILARS</acronym>
  <official_title>A Prospective, Randomized, Open, Parallel Trial of Transanal Irrigation to Prevent Major Low Anterior Resection Syndrome in Rectal Cancer Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sixth Affiliated Hospital, Sun Yat-sen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sixth Affiliated Hospital, Sun Yat-sen University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Bowel dysfunction after rectal cancer resection comprises a vast array of bowel symptoms and&#xD;
      associated quality-of-life impairment, collectively termed as low anterior resection syndrome&#xD;
      (LARS). There are 40%-60% patients who suffer from major LARS after sphincter-preserving&#xD;
      surgery. No consensus exists for LARS treatment or prevention. Transanal irrigation (TAI) was&#xD;
      reported to play a helpful role in the management of major LARS and fecal incontinence.&#xD;
      However, the preventive effect and daily accessibility need further confirmation. In this&#xD;
      randomized trial, TAI compared with best support treatment, is used in patients who received&#xD;
      curative low anterior resection for rectal cancer with diverting stoma, after completion of&#xD;
      the stoma reversal. The primary outcome is the occurrence of major LARS after 6 months of the&#xD;
      treatment.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2021</start_date>
  <completion_date type="Anticipated">June 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of participants with major low anterior resection syndrome score (LARS score)</measure>
    <time_frame>at the time of 6 months since the start of treatment</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of life impairment assessed by Short Form 36 (SF-36)</measure>
    <time_frame>at the time of 6, 12 months since the start of treatment</time_frame>
    <description>Quality of life will be assessed by Short Form 36 (SF-36) health questionnaire.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with major low anterior resection syndrome score (LARS score)</measure>
    <time_frame>at the time of 1, 3, 12 months since the start of treatment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bowel function impairment</measure>
    <time_frame>at the time of 6, 12 months since the start of treatment</time_frame>
    <description>Bowel function will be assessed by Memorial Sloan Kettering Cancer Centre Bowel Function Instrument (MSKCC BFI). Stool frequency will be recorded in the day and night.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fecal continence impairment</measure>
    <time_frame>at the time of 6, 12 months since the start of treatment</time_frame>
    <description>Fecal incontinence will be assessed by Wexner incontinence scale.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Anorectal function impairment</measure>
    <time_frame>at the time of 6 months since the start of treatment</time_frame>
    <description>Anorectal function will be assessed by anorectal manometry.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Low Anterior Resection Syndrome</condition>
  <arm_group>
    <arm_group_label>Transanal irrigation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Transanal irrigation (TAI) is performed using the irrigation bag, electronic irrigation system, or balloon catheter with syringe. TAI is performed with up to 2000 ml tap water every 24-48 hours (3-7 times per week) over the course of 6 months.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Best supportive therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Best supportive therapy consists of dietary modification, pelvic floor muscle training, biofeedback, and necessary medication.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Transanal irrigation</intervention_name>
    <description>Transanal irrigation (TAI) is performed using the irrigation bag, electronic irrigation system, or balloon catheter with syringe. TAI is performed with up to 2000 ml tap water every 24-48 hours (3-7 times per week) over the course of 6 months.</description>
    <arm_group_label>Transanal irrigation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Best supportive therapy</intervention_name>
    <description>Best supportive therapy consists of dietary modification, pelvic floor muscle training, biofeedback, and necessary medication.</description>
    <arm_group_label>Best supportive therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age: 18-75 years old&#xD;
&#xD;
          -  Curative low anterior resection for rectal cancer with diverting stoma&#xD;
&#xD;
          -  Stoma closure within 1 month&#xD;
&#xD;
          -  Preoperative radiotherapy or height of anastomosis less than 5 cm from anal verge&#xD;
&#xD;
          -  No evidence of anastomotic leakage or severe stenosis&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Tumor recurrence or distant metastasis&#xD;
&#xD;
          -  Secondary operation with stoma&#xD;
&#xD;
          -  Prior disease impairing bowel function except for rectal cancer&#xD;
&#xD;
          -  Any contraindication for transanal irrigation&#xD;
&#xD;
          -  Pregnant or nursing&#xD;
&#xD;
          -  Serious cardiovascular disease, uncontrolled infections, or other serious uncontrolled&#xD;
             concomitant disease&#xD;
&#xD;
          -  Cognitive or psychological disorder&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Qiyuan Qin, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Sixth Affiliated Hospital, Sun Yat-sen University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Qiyuan Qin, M.D.</last_name>
    <phone>86-20-38254052</phone>
    <email>qinqy3@mail.sysu.edu.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>Sixth Affiliated Hospital, Sun Yat-sen University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Qiyuan Qin, M.D.</last_name>
      <phone>86-20-38254052</phone>
      <email>qinqy3@mail.sysu.edu.cn</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>February 15, 2021</study_first_submitted>
  <study_first_submitted_qc>February 16, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 17, 2021</study_first_posted>
  <last_update_submitted>March 1, 2021</last_update_submitted>
  <last_update_submitted_qc>March 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Low Anterior Resection Syndrome</keyword>
  <keyword>Transanal irrigation</keyword>
  <keyword>Rectal cancer</keyword>
  <keyword>Prevention</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

